This study is not accepting new patients
Early Access Program With Arimoclomol in US Patients With NPC
Summary
- Eligibility
- for people ages 2 years and up (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study started
- Principal Investigator
- by Caroline Hastings, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Caroline Hastings, MD
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 10 research publications. Research interests: Neuro Oncology · Acute lymphoblastic leukemia · Niemann Pick Type C · Gangliosidosis · Lysosomal storage diseases · Sickel Cell disease
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- ZevraDenmark
- ID
- NCT04316637
- Study Type
- Expanded Access
- Last Updated